| Structure | Chemical Name | CAS | MF |
|
Adenosine-13C5
|
159496-13-6
|
C10H13N5O4
|
|
[1',2',3',4',5''-13C5]Uridine
|
159496-16-9
|
C9H12N2O6
|
|
5-Methyl-[1',2',3',4',5'-13C5]uridine
|
159496-17-0
|
C10H14N2O6
|
|
1H-Indene-1-carboxaldehyde, 2,3-dihydro-, (+)- (9CI)
|
159496-97-6
|
C10H10O
|
|
2-((1-Methylpyrrolidin-2-yl)methyl)isoindoline dihydrochloride
|
159497-37-7
|
C14H20N2
|
|
4-Desacetyl-2-debenzoyl-[2,4]-oxol Paclitaxel
|
159500-49-9
|
C40H47NO13
|
|
Cidp-ribose
|
159501-36-7
|
C15H20N4O14P2
|
|
4'-Amino-biphenyl-3-carboxylic acid methyl ester
|
159503-24-9
|
C14H13NO2
|
|
Cyclobutanepropanoic acid, alpha-chloro-beta-oxo- (9CI)
|
159503-27-2
|
C7H9ClO3
|
|
1H-Indole-3-MethanaMine, 7-chloro-N,N-diMethyl-
|
159503-76-1
|
C11H13ClN2
|
|
tert-butyl 4-broMo-5,6-dihydropyridine-1(2H)-carboxylate
|
159503-91-0
|
C10H16BrNO2
|
|
2-Thiophenethiol,5-amino-(9CI)
|
159504-43-5
|
C4H5NS2
|
|
H-Tyr(Tos)-OH
|
159505-46-1
|
C15H14NO.CH3O4S
|
|
Fmoc-D-Phe-OPfp
|
159505-85-8
|
C30H20F5NO4
|
|
3-(Benzyloxy)-5-hydroxybenzoic acid
|
159506-17-9
|
C14H12O4
|
|
distel(2+)
|
159506-80-6
|
C42H47N11O5
|
|
URAYPUMNDPQOKB-RDBQKVEJSA-N
|
159510-46-0
|
C9H14O6
|
|
Cyclohexanecarboxylic acid, 3-amino-2-hydroxy-, ethyl ester, (1alpha,2alpha,3beta)- (9CI)
|
159515-45-4
|
C9H17NO3
|
|
Cyclohexanecarboxylic acid, 3-amino-2-hydroxy-, ethyl ester, (1alpha,2beta,3beta)- (9CI)
|
159515-47-6
|
C9H17NO3
|
|
(2R)-2-Amino-3-phenylpropanenitrile
|
159517-27-8
|
C9H10N2
|
|
Benzeneacetonitrile, 4-fluoro-alpha-methyl-, (S)- (9CI)
|
159517-51-8
|
C9H8FN
|
|
poly(Ethyleneglycol)jojobaacid
|
159518-81-7
|
|
|
|
Macadamianutoil
|
159518-86-2
|
|
|
|
Chromium, acetylated 6-amino-4-hydroxy-2-naphthalenesulfonic acid-p-cresol-diazotized 2-hydroxy-5-nitrobenzenesulfonic acid-diazotized 4-hydroxy-3-nitrobenzenesulfonic acid coupling products ammonium potassium sodium complexes
|
159518-93-1
|
|
|
3-Chloro-2-[[(5-ethoxy-7-fluoro[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)sulfonyl]amino]benzoic acid
|
159518-97-5
|
C14H11ClFN5O5S
|
|
Enfuvirtide
|
159519-65-0
|
C204H301N51O64
|
|
Drosomycin
|
159522-55-1
|
C204H311N65O68S8
|
|
Cyclohexane, 1-ethynyl-4-propyl-, trans- (9CI)
|
159524-85-3
|
C11H18
|
|
Benzoic acid, 2-amino-5-(1-pyrrolidinyl)- (9CI)
|
159526-21-3
|
C11H14N2O2
|
|
4,4'-(9H -fluoren-9-ylidene)bis[N,N-bis(4-methylphenyl)- benzenamine
|
159526-57-5
|
C53H44N2
|
|
N-CBz-O-(2-benzyloxyethyl)-L-serine
|
159526-79-1
|
C20H23NO6
|
|
(+)-(2S)-9-benzyloxy-2-(N-benzyloxycarbonylamino)-
4,7-dioxanonanoic acid
|
159526-80-4
|
C22H27NO7
|
|
(+)-(2S)-12-benzyloxy-2-(N-benzyloxycarbonylamino)-
4,7,10-trioxadodecanoic acid
|
159526-81-5
|
C24H31NO8
|
|
Cbz-Ser(azido-PEG2)-OH
|
159526-82-6
|
C15H20N4O6
|
|
(+)-(2S)-12-azido-2-(N-benzyloxycarbonylamino)-
4,7,10-trioxadodecanoic acid
|
159526-83-7
|
C17H24N4O7
|
|
Indeno[1,2-d]-1,3-dioxin, 4,4a,5,9b-tetrahydro-2-methyl- (9CI)
|
159527-17-0
|
C12H14O2
|
|
5-Thia-1-azabicyclo[4.2.0]octane-2-carboxylicacid,7-amino-8-oxo-(9CI)
|
159527-24-9
|
C7H10N2O3S
|
|
Ethanone, 1-[4-(1,2-propadienyl)phenyl]- (9CI)
|
159527-72-7
|
C11H10O
|
|
3-Methoxybenzonitrile-cyano-13C
|
159528-75-3
|
C8H7NO
|
|
2-Methyl-4-phenylindene
|
159531-97-2
|
C16H14
|
|
Fluconazole (Mesylate)
|
159532-41-9
|
C14H16F2N6O4S
|
|
(S)-4-Boc-Piperazine-3-carboxylic acid
|
159532-59-9
|
C10H18N2O4
|
|
3-[3-(dimethylamino)propyl]-4-hydroxy-N-(4-pyridin-4-ylphenyl)benzamide:dihydrochloride
|
159533-25-2
|
C23H27Cl2N3O2
|
|
1-(5-Bromopyridin-2-yl)-ethanol
|
159533-68-3
|
C7H8BrNO
|
|
Ethyl ximenynate
|
159534-89-1
|
C20H34O2
|
|
hapalosin
|
159542-04-8
|
C28H43NO6
|
|
3-Furancarboxaldehyde, tetrahydro-2,5-dimethoxy-, [2R-(2alpha,3alpha,5alpha)]- (9CI)
|
159551-27-6
|
C7H12O4
|
|
3-Furancarboxaldehyde, tetrahydro-2,5-dimethoxy-, [2S-(2alpha,3alpha,5alpha)]- (9CI)
|
159551-28-7
|
C7H12O4
|
|
3-Furancarboxaldehyde, tetrahydro-2,5-dimethoxy-, [2R-(2alpha,3beta,5alpha)]- (9CI)
|
159551-29-8
|
C7H12O4
|
|
3-Furancarboxaldehyde, tetrahydro-2,5-dimethoxy-, [2S-(2alpha,3beta,5alpha)]- (9CI)
|
159551-30-1
|
C7H12O4
|
|
3-Furancarboxaldehyde, tetrahydro-2,5-dimethoxy-, [2R-(2alpha,3alpha,5beta)]- (9CI)
|
159551-31-2
|
C7H12O4
|
|
3-Furancarboxaldehyde, tetrahydro-2,5-dimethoxy-, [2S-(2alpha,3alpha,5beta)]- (9CI)
|
159551-32-3
|
C7H12O4
|
|
3-Furancarboxaldehyde, tetrahydro-2,5-dimethoxy-, [2R-(2alpha,3beta,5beta)]- (9CI)
|
159551-33-4
|
C7H12O4
|
|
3-Furancarboxaldehyde, tetrahydro-2,5-dimethoxy-, [2S-(2alpha,3beta,5beta)]- (9CI)
|
159551-34-5
|
C7H12O4
|
|
1H-Indole, octahydro-1-(trifluoroacetyl)-, cis-(+)- (9CI)
|
159551-35-6
|
C10H14F3NO
|
|
1H-Indole, octahydro-1-(trifluoroacetyl)-, cis-(-)- (9CI)
|
159551-36-7
|
C10H14F3NO
|
|
1H-Indole, octahydro-1-(trifluoroacetyl)-, trans-(+)- (9CI)
|
159551-37-8
|
C10H14F3NO
|
|
1H-Indole, octahydro-1-(trifluoroacetyl)-, trans-(-)- (9CI)
|
159551-38-9
|
C10H14F3NO
|
|
7-Benzothiazolesulfonicacid(9CI)
|
159555-57-4
|
C7H5NO3S2
|
|
6-Oxa-3-azabicyclo[3.1.0]hexane, 3-[(4-Methylphenyl)sulfonyl]-
|
159555-66-5
|
C11H13NO3S
|
|
3-Azetidinone, 1-diphenylMethyl-2,2-diMethyl-
|
159556-72-6
|
C18H19NO
|
|
1-(diphenylmethyl)-2,2-dimethylazetidin-3-ol
|
159556-73-7
|
C18H21NO
|
|
(2S,3R)-1-(diphenylmethyl)-2-methylazetidine-3-carbonitrileļ¼rel-
|
159556-79-3
|
C18H18N2
|
|
HDH-PHARMA 24737
|
159557-47-8
|
C17H25NO3
|
|
Methanamine, 1-(3-butenyloxy)-N,N-dimethyl- (9CI)
|
159558-06-2
|
C7H15NO
|
|
8-hydroxy-2-(N-n-propyl-N-(3'-iodo-2'-propenyl)amino)tetralin
|
159559-70-3
|
C16H22INO
|
|
(RS)-trans-7-Hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino]tetralin maleate
|
159559-71-4
|
C16H22INO
|
|
5-[4-(trans-4-Ethylcyclohexyl)-1-cyclohexen-1-yl]-1,2,3-trifluorbenzol
|
159560-06-2
|
C20H25F3
|
|
1-Pyrrolidineacetaldehyde, 2-formyl-3-hydroxy-, (2R-cis)- (9CI)
|
159561-66-7
|
C7H11NO3
|
|
[(2R,3R)-1,1-dioxo-2-propan-2-yl-thiolan-3-yl] N-[(2S,3R)-3-hydroxy-4- [(2S)-4-[(3-hydroxyphenyl)methyl]-2-(tert-butylcarbamoyl)piperazin-1-y l]-1-phenyl-butan-2-yl]carbamate
|
159565-69-2
|
C34H50N4O7S
|
|
Carbamic acid, [3-[4-[(2-chloro-6-methyl-4-pyridinyl)methyl]-2-[[(1,1- dimethylethyl)amino]carbonyl]-1-piperazinyl]-2-hydroxy-1-(phenylmethyl )propyl]-, tetrahydro-2-(1-methylethyl)-1,1-dioxido-3-thienyl ester, [ 2R-[2a,3a[1S*,2R*,3(S*)]]]-
|
159565-70-5
|
C34H50ClN5O6S
|
|
2H-Pyran-2-carboxylicacid,tetrahydro-,methylester,(S)-(9CI)
|
159572-48-2
|
C7H12O3
|
|
2-Piperazinecarboxamide,(2S)-(9CI)
|
159572-93-7
|
C5H11N3O
|
|
|
Cuprate(4-), 7-4-5-5-chlorodifluoro-2(or 4)-pyrimidinylamino-2-methoxy-3-sulfophenylazo-2-(hydroxy-.kappa.O)phenylazo-.kappa.N1-8-(hydroxy-.kappa.O)-1,3,6-naphthalenetrisulfonato(6-)-, potassium sodium (5:4:16)
|
159574-71-7
|
|
|
Chromate(5-), bis4-hydroxy-7-(2-hydroxy-1-naphthalenyl)azo-3-(2-hydroxy-3-nitro-5-sulfophenyl)azo-2-naphthalenesulfonato(4-)-, pentasodium
|
159574-72-8
|
C52H30CrN10Na5O22S4+4
|
|
Cyclohexanecarboxylic acid, 3-(hydroxyimino)-2-methoxy-, methyl ester, (1S-cis)- (9CI)
|
159581-81-4
|
C9H15NO4
|
|
5-Pyrimidinecarboxylicacid,1,2,3,4-tetrahydro-6-methyl-2-thioxo-,ethylester(9CI)
|
159582-41-9
|
C8H12N2O2S
|
|
Ethanone, 1-(1,2,3,4-tetrahydro-6-methyl-2-thioxo-5-pyrimidinyl)- (9CI)
|
159582-42-0
|
C7H10N2OS
|
|
4-Pyridazinamine,hexahydro-1,2-dimethyl-(9CI)
|
159583-29-6
|
C6H15N3
|
|
1(2H)-Pyridazineacetonitrile,tetrahydro-2-methyl-(9CI)
|
159583-33-2
|
C7H13N3
|
|
1(2H)-Pyridazineethanamine,tetrahydro-2-methyl-(9CI)
|
159583-34-3
|
C7H17N3
|
|
2,3-Diazabicyclo[2.2.1]heptane-2-acetonitrile,3-methyl-(9CI)
|
159583-37-6
|
C8H13N3
|
|
2,3-Diazabicyclo[2.2.1]heptane-2-ethanamine,3-methyl-(9CI)
|
159583-38-7
|
C8H17N3
|
|
2-Chloro-5-iodo-4-methoxypyrimidine
|
159585-16-7
|
C5H4ClIN2O
|
|
4-Oxazolidinecarboxylicacid,2,2-dimethyl-,(S)-(9CI)
|
159585-65-6
|
C6H11NO3
|
|
2-(1H-Imidazol-1-yl)benzoic acid
|
159589-67-0
|
C10H8N2O2
|
|
2-(4-Methyl-piperazin-1-yl)-benzoic acid
|
159589-70-5
|
C12H16N2O2
|
|
2-(2-Methyl-1H-imidazol-1-yl)benzoic acid
|
159589-71-6
|
C11H10N2O2
|
|
1H-IMidazole, 2,4,5-tribroMo-1-[[2-(triMethylsilyl)ethoxy]Methyl]-
|
159590-01-9
|
C9H15Br3N2OSi
|
|
1-(tert-Butyldimethylsilyl)-1H-indole-3-boronic acid
|
159590-02-0
|
C14H22BNO2Si
|
|
1,2-bis(2'-methyl-5'-bromothien-3'-yl)perfluorocyclopentene
|
159590-16-6
|
C15H8Br2F6S2
|
|
Methyl 4-(benzo[1,3]dioxol-5-yl-carboxymethoxy)-3-propylbenzoate
|
159590-92-8
|
C20H20O7
|
|
methyl 4-(1-(benzo[d][1,3]dioxol-5-yl)-2-ethoxy-2-oxoethoxy)-3-propylbenzoate(WXG01786)
|
159591-45-4
|
C22H24O7
|
|
Benzenesulfonamide, 4-(ethenyloxy)- (9CI)
|
159591-65-8
|
C8H9NO3S
|
|
4-Morpholino-2-naphthol
|
159596-05-1
|
C14H15NO2
|
|
3-Cyclobutene-1,2-dione,3-ethoxy-4-(4-pyridinylamino)-(9CI)
|
159596-50-6
|
C11H10N2O3
|
|
3-Cyclobutene-1,2-dione,3-ethoxy-4-(3-pyridinylamino)-(9CI)
|
159596-51-7
|
C11H10N2O3
|
|
2-Azetidinone, 4-acetyl-3-methoxy-1-methyl-, cis- (9CI)
|
159597-50-9
|
C7H11NO3
|
|
11-Methylforsythide
|
159598-00-2
|
C17H24O11
|
|
1H-Benzimidazole,5-methyl-2-[(methylthio)methyl]-(9CI)
|
159598-38-6
|
C10H12N2S
|